• Most Popular
  • Most Shared

Epix to stop clinical development of depression drug

Thu Mar 20, 2008 7:26am EDT

March 20 (Reuters) - Epix Pharmaceuticals Inc EPIX.O said it will discontinue clinical development of its drug to treat severe depression, due to lack of sufficient effectiveness shown in the recently completed mid-stage trial.

Stocks  |  Global Markets

While the drug, PRX-00023, continued to show a good safety and tolerability profile, the overall results of the mid-stage trial was disappointing, Chief Executive Michael Kauffman said. (Reporting by Sweta Singh; Editing by Jarshad Kakkrakandy)

Stocks
Global Markets


More from Reuters

Photo

Saab says bid deadline dropped

AMSTERDAM (Reuters) - General Motors has extended a December 31 deadline for bids for its Swedish car brand Saab, which will restart some production lines in January after a shutdown, Saab said on Wednesday.

» More Top News
Maria Montero carries plastic products for quality control inspection at Blow Molded Plastics in Pawtucket, Rhode Island November 17, 2009. REUTERS/Brian Snyder

Learning to survive and thrive

Small manufacturers in states like Alabama are taking a risk on innovation to compete with with low-cost competition. It's working. The second installment in a three-part report.  Full Article 

Route to Recovery
Disgraced financier Bernard Madoff is escorted by police and photographed by the media as he departs U.S. Federal Court after a hearing in New York, January 5, 2009. REUTERS/Lucas Jackson

I beg your pardon ...

Bernie Madoff became the poster boy of crooked investment schemes this year -- but he wasn't alone. Here's a look at the 10 most notorious cases of 2009.  Full Article 

Corporate Crime